Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study

BACKGROUND: The World Health Organization has defined a list of adverse events of special interest (AESI) for safety surveillance of vaccines. AESI have not been adequately assessed following COVID-19 vaccination in patients with cancer contributing to vaccine hesitancy in this population. We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Wei, Shami, Jessica J. P., Yan, Vincent K. C., Ye, Xuxiao, Blais, Joseph E., Li, Xue, Lee, Victor H. F., Chui, Celine S. L., Lai, Francisco T. T., Wan, Eric Y. F., Wong, Carlos K. H., Wong, Ian C. K., Chan, Esther W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117990/
https://www.ncbi.nlm.nih.gov/pubmed/35590336
http://dx.doi.org/10.1186/s13045-022-01265-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117990/
https://www.ncbi.nlm.nih.gov/pubmed/35590336
http://dx.doi.org/10.1186/s13045-022-01265-9

Ejemplares similares